Highlights:
add free Download App
premium Premium Account

Last Price Change Volume
Open: Day Range: Prev Close:


OTHERS KANGER INTERNATIONAL BERHAD ("KANGER" OR "THE GROUP") UPDATE ON EXECUTION HEAD OF AGREEMENT BETWEEN KANGER MEDICAL INTERNATIONAL SDN. BHD. AND SPARMAK MEDICAL EQUIPMENT TRADING LLC

KANGER INTERNATIONAL BERHAD

Type Announcement
Subject OTHERS
Description
KANGER INTERNATIONAL BERHAD ("KANGER" OR "THE GROUP")
UPDATE ON EXECUTION HEAD OF AGREEMENT BETWEEN KANGER MEDICAL INTERNATIONAL SDN. BHD. AND SPARMAK MEDICAL EQUIPMENT TRADING LLC

Reference is made to the announcement dated 19 July 2021 pertaining to the Head of Agreement between Kanger Medical International Sdn. Bhd., a wholly-owned subsidiary of the Company and Sparmak Medical Equipment Trading LLC for purchase of inactivated SARS-COV-2 Vaccines (Vero Cell) vaccine developed by Beijing Institute of Biological Products Co. Ltd., an affiliate of SINOPHARM CNBG.

The Board of Directors of Kanger wishes to announce that the Company is still waiting for the approval from National Pharmaceutical Regulatory Agency (NPRA).

This announcement is dated 18 October 2021.

 






Announcement Info

Company Name KANGER INTERNATIONAL BERHAD
Stock Name KANGER
Date Announced 18 Oct 2021
Category General Announcement for PLC
Reference Number GA1-15102021-00077




Close